This Funding Opportunity Announcement (FOA) issued by the National Institute of Mental Health (NIMH) invites Phased Innovation (R21/R33) grant applications from organizations /institutions that propose the development and characterization of novel mouse models that express human genes or human genetic elements that can aid in understanding the molecular mechanisms underlying brain development and function and the physiological function/significance of gene variants and gene dosage abnormalities that have been identified as putative candidates in genome association studies of mental disorders and by other means. -Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental Grant Phase II Phased Innovation Grant (R21/R33) award mechanisms. Applicants will submit a single application organized into two phases, beginning with discussion of the R21 phase followed by discussion of the R33 phase -Funds Available and Anticipated Number of Awards. The NIMH intends to commit approximately $1,750,000 to fund 7 to 10 grants submitted in response to this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Link to Full Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-08-050.html
If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment